SCHEMBL801143

SCHEMBL801143

O=P(c1ccccc1)(c1cc(-n2c3ccccc3c3ccccc32)cc(P(=O)(c2ccccc2)c2cccc3ccccc23)c1)c1cccc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ ATM Q13315 1/20 0.41
▸ NPSR1 Q6W5P4 4/20 0.40
▸ TOP1 P11387 1/20 0.37
▸ POLB P06746 3/20 0.35
▸ LMNA P02545 1/20 0.35
▸ KMT2A Q03164 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.31
▸ HTT P42858 1/20 0.31
▸ PTK2B Q14289 1/20 0.31
▸ TUBB4A P04350 1/20 0.31
▸ TUBB P07437 1/20 0.31
▸ TUBA3C P0DPH7 1/20 0.31
▸ TUBA1B P68363 1/20 0.31
▸ TUBA4A P68366 1/20 0.31
▸ TUBB4B P68371 1/20 0.31
▸ TUBB3 Q13509 1/20 0.31
▸ TUBB2A Q13885 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL801442 0.93 KDM4E (0.41) KDM4EL3MBTL1ATMNPSR1POLB
SCHEMBL801204 0.85 KDM4E (0.52) KDM4EL3MBTL1ATMNPSR1POLB
SCHEMBL30780039 0.85 KDM4E (0.52) KDM4EL3MBTL1ATMNPSR1POLB
SCHEMBL14339268 0.85 POLB (0.44) KDM4EL3MBTL1NPSR1TOP1POLB
SCHEMBL801512 0.85 KDM4E (0.40) KDM4EL3MBTL1ATMNPSR1TOP1
SCHEMBL14923168 0.82 KDM4E (0.52) KDM4EL3MBTL1ATMNPSR1POLB
SCHEMBL29551411 0.82 KDM4E (0.52) KDM4EL3MBTL1ATMNPSR1POLB
SCHEMBL801540 0.82 KDM4E (0.42) KDM4EL3MBTL1ATMNPSR1LMNA
SCHEMBL801506 0.81 KDM4E (0.41) KDM4EL3MBTL1ATMNPSR1LMNA
SCHEMBL801106 0.81 ATM (0.43) KDM4EL3MBTL1ATMNPSR1TOP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INPP5B, EZH2, PLCB3 KDM4E 1186/4885L3MBTL1 1822/4885ATM 3758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback